Tandem Diabetes Care | TNDM - Nettoeinkommen

Aktienkurs
21.14
Täglich Wechseln
-1.49 -6.58%
Monatlich
11.91%
Jährlich
17.71%
Q1 Prognose
20.49




Nettoeinkommen Veränderung Datum
Abbott USD 1.78B 132M 2025-12
Accuray USD 2.54M 6.49M 2024-12
Align Technology USD 135.76M 79.01M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Cooper Companies USD 84.6M 13.7M 2025-09
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
J&J USD 5.12B 36M 2025-12
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Orthofix International USD -126M 98.61M 2024-12
Roche Holding CHF 5.47B 1.76B 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12